4 Jan 2013

A major task for clinical and routine toxicology screening is the reliable, fast and comprehensive identification of drugs and drugs of abuse (DOA). LC-MS/MS is an emerging technology that is more specific than immunoassays, provides more information than LC-UV/DAD detection, and covers a broader range of compounds than GC-MS. This application note describes a robust and automated screening solution based on the latest LC-MS/MS ion trap technology that promises to provide a combination of the highest performance LC-MS/MS and easy-to-use screening with the greatest transferability of results from lab to lab.